<DOC>
	<DOCNO>NCT01954121</DOCNO>
	<brief_summary>To demonstrate non-inferiority Levetiracetam ( 1000 mg/day ) versus Carbamazepine Immediate-Release ( 400 mg/day ) use monotherapy least 6 month Chinese population newly recently diagnose Epilepsy experience Partial-Onset Seizures ( POS ) .</brief_summary>
	<brief_title>Open-label , Randomized , Active-controlled Study LEV Used Monotherapy Patients With Partial-Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subject Chinese origin â‰¥ 16 year age Subject newly recently diagnose Epilepsy , experience unprovoked PartialOnset Seizures ( POS ) Subject experience least 2 unprovoked seizure year precede randomization , least 1 unprovoked seizure occur 3 month precede randomization Subject Electroencephalogram ( EEG ) brain Computed Tomography ( CT ) scan brain Magnetic Resonance Imaging ( MRI ) scan consistent diagnosis Epilepsy POS Subject test positive human leukocyte antigen major histocompatibility complex , class I , B ( HLAB ) * 1502 allele Subject history presence seizures type PartialOnset Seizures ( POS ) Subject experience type IA nonmotor seizure Subject history presence seizures occur cluster pattern Subject history clinical Electroencephalogram ( EEG ) finding suggestive Idiopathic Generalized Epilepsy prior randomization Subject current previous diagnosis pseudoseizures , conversion disorder , nonepileptic ictal event could confuse seizure Subject history Status Epilepticus</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>Keppra</keyword>
	<keyword>Monotherapy</keyword>
	<keyword>China</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Partial-onset Seizures</keyword>
</DOC>